‘Harder to find homes’: Latest wave of biotech layoffs could test the industry
A quarters-long flurry of layoffs has caused thousands of workers in life sciences to go hunting for their next position sooner than expected, and the latest wave could make it more difficult to get new offers in hand in short order.
At least three dozen biotechs let employees go so far this year, based on Endpoints News reporting, with more having done so under the radar. More than 100 drug developers thinned their organization charts last year.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.